| Biopiracy and beyond: a consideration of socio-cultural conflicts with global patent policies CM Ho U. Mich. JL Reform 39, 433, 2005 | 100 | 2005 |
| Splicing morality and patent law: Issues arising from mixing mice and men CM Ho Wash. UJL & Pol'y 2, 247, 2000 | 98 | 2000 |
| Access to medicine in the global economy: international agreements on patents and related rights C Ho Oxford University Press, 2011 | 91 | 2011 |
| Patents, Patients, and Public Policy: An Incomplete Intersection at 35 USC 287 (c) CM Ho UC Davis L. Rev. 33, 601, 1999 | 66 | 1999 |
| Patent Breaking or Balancing: separating Strands of Fact from Fiction under Trips CM Ho NCJ Int'l L. & Com. Reg. 34, 371, 2008 | 64 | 2008 |
| Regime shifting of IP lawmaking and enforcement from the WTO to the international investment regime J Gathii, C Ho Minn. JL Sci. & Tech. 18, 427, 2017 | 58 | 2017 |
| Sovereignty under siege: Corporate challenges to domestic intellectual property decisions CM Ho Berkeley Tech. LJ 30, 213, 2015 | 58 | 2015 |
| Should all drugs be patentable: A comparative perspective CM Ho Vand. J. Ent. & Tech. L. 17, 295, 2014 | 52 | 2014 |
| A New World Order for Addressing Patent Rights and Public Health CM Ho Chi.-Kent L. Rev. 82, 1469, 2007 | 50 | 2007 |
| Unveiling competing patent perspectives CM Ho Hous. L. Rev. 46, 1047, 2009 | 47 | 2009 |
| Drugged Out: How Cognitive Bias Hurts Drug Innovation CM Ho San Diego L. Rev. 51, 419, 2014 | 44 | 2014 |
| A collision course between TRIPS flexibilities and investor-state proceedings CM Ho UC Irvine L. Rev. 6, 395, 2016 | 32 | 2016 |
| Building a better mousetrap: patenting biotechnology in the European Community CM Ho Duke J. Comp. & Int'l L. 3, 173, 1992 | 23 | 1992 |
| Global Access to Medicine: The Influence of Competing Patent Perspectives CM Ho Fordham Int'l LJ 35, 1, 2011 | 22 | 2011 |
| Attacking the Copyright Evildoers in Cyberspace CM Ho SMUL Rev. 55, 1561, 2002 | 19 | 2002 |
| An active-learning approach to teaching tough topics C Ho, A Upchurch, S Gilles Journal of Legal Education 65 (4), 772-816, 2016 | 18 | 2016 |
| Lessons from Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc. CM Ho Santa Clara Computer & High Tech. LJ 23, 463, 2006 | 17* | 2006 |
| A dangerous concoction: Pharmaceutical marketing, cognitive biases, and First Amendment overprotection CM Ho Ind. LJ 94, 773, 2019 | 15 | 2019 |
| Disclosure of Origin and Prior Informed Consent for Applications of Intellectual Property Rights Based on Genetic Resources—A Technical Study of Implementation Issues CM Ho, CE Vickrey Final Report, 2003 | 14 | 2003 |
| Who Deserves the Patent Pot of Gold: An Inquiry into the Proper Inventorship of Patient-Based Discoveries CM Ho DePaul J. Health Care L. 7, 185, 2003 | 13 | 2003 |
